Free Trial

Fennec Pharmaceuticals (FRX) Insider Trading & Ownership

Fennec Pharmaceuticals logo
C$8.67 +0.16 (+1.88%)
(As of 12/17/2024 ET)

Fennec Pharmaceuticals (TSE:FRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.20%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
C$112,360.75
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
C$455,891.17
Get FRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fennec Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FRX Insider Buying and Selling by Quarter

Fennec Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2024Rostislav Christov RaykovDirectorBuy796C$8.52C$6,779.05
11/18/2024Robert Christopher AndradeSenior OfficerBuy15,816C$3.43C$54,248.88
10/8/2024Chris Anigeron RallisDirectorSell1,406C$6.16C$8,662.08
10/2/2024Rostislav Christov RaykovDirectorSell2,431C$6.67C$16,212.34
9/4/2024Rostislav Christov RaykovDirectorSell2,431C$7.45C$18,115.81
7/5/2024Chris Anigeron RallisDirectorSell1,173C$6.03C$7,073.19
7/1/2024Rostislav Christov RaykovDirectorSell2,431C$6.13C$14,902.03
4/23/2024Adrian J. HaighSenior OfficerSell22,223C$9.32C$207,029.47
4/15/2024Adrian J. HaighSenior OfficerBuy22,222C$2.31C$51,332.82
4/15/2024Chris Anigeron RallisDirectorSell800C$10.45C$8,360.00
3/26/2024Chris Anigeron RallisDirectorSell2,114C$10.97C$23,190.58
3/26/2024Robert Christopher AndradeSenior OfficerSell13,975C$10.90C$152,345.67
(Data available from 1/1/2013 forward)

FRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Fennec Pharmaceuticals includes Adrian J. Haigh, Chris Anigeron Rallis, Khalid Islam, Robert Christopher Andrade, and Rostislav Christov Raykov. Learn more on insiders at FRX.

16.20% of Fennec Pharmaceuticals stock is owned by insiders. Learn more on FRX's insider holdings.

The following insiders have purchased FRX shares in the last 24 months: Adrian J. Haigh (C$51,332.82), Khalid Islam (C$50,000.48), Robert Christopher Andrade (C$54,248.88), and Rostislav Christov Raykov (C$125,699.92).

Insiders have purchased a total of 134,119 FRX shares in the last 24 months for a total of C$281,282.10 bought.

The following insiders have sold FRX shares in the last 24 months: Adrian J. Haigh (C$207,029.47), Chris Anigeron Rallis (C$57,144.54), Robert Christopher Andrade (C$152,345.67), and Rostislav Christov Raykov (C$49,230.18).

Insiders have sold a total of 50,169 Fennec Pharmaceuticals shares in the last 24 months for a total of C$465,749.86 sold.

Fennec Pharmaceuticals Key Executives

  • Mr. Rostislav Raykov (Age 48)
    CEO & Director
    Compensation: $1.2M
  • Mr. Robert C. Andrade (Age 49)
    Chief Financial Officer
    Compensation: $817.74k
  • Mr. Adrian J. Haigh (Age 65)
    Chief Operating Officer
    Compensation: $886.92k
  • Mr. Mark Gowland
    Controller
  • Mr. Lei Fang
    President of Pharstat Inc


This page (TSE:FRX) was last updated on 12/17/2024 by MarketBeat.com Staff
From Our Partners